- Home
- CAN vs CLPT Comparison
CAN vs CLPT Comparison
Compare CAN & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CAN | CLPT |
|---|---|---|
| Founded | 2013 | 1998 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 427.9M | 435.7M |
| IPO Year | 2019 | 2009 |
Fundamental Metrics
Financial Performance| Metric | CAN | CLPT |
|---|---|---|
| Price | $0.17 | $15.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $3.21 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 10.7M | 471.4K |
| Earning Date | 05-19-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | N/A | $45.67 |
| Revenue Next Year | $63.64 | $19.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $0.17 | $8.27 |
| 52 Week High | $2.22 | $30.10 |
Technical Indicators
Market Signals| Indicator | CAN | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 25.12 | 49.92 |
| Support Level | N/A | $14.71 |
| Resistance Level | $0.56 | $16.54 |
| Average True Range (ATR) | 0.02 | 0.75 |
| MACD | -0.01 | -0.11 |
| Stochastic Oscillator | 3.50 | 63.54 |
Price Performance
Historical ComparisonAbout CAN Canaan Inc.
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.